Taiwania Capital

Established in August 2017, Taiwania Capital is a venture capital firm founded by the National Development Fund of the Executive Yuan of Taiwan and private enterprises. The firm focuses on investing in early to growth-stage technology and biotech startups, aiming to connect Taiwan's robust tech and biotech ecosystems with global innovations. Taiwania Capital manages multiple funds and has offices in Taiwan, the United States, Japan, Southeast Asia, and Central and Eastern Europe.

Taiwania Capital's investment strategy encompasses a wide geographical focus, including Taiwan, the United States, Japan, Southeast Asia, and Central and Eastern Europe. The firm invests across various stages, from seed to late-stage companies, and has a particular emphasis on technology and biotech sectors.

The firm's mission is to establish partnerships with companies worldwide to boost Taiwan's economic growth. Taiwania Capital has a track record of supporting portfolio companies with resources to enhance their growth and market penetration, contributing to the development of next-generation emerging technologies and Taiwan's innovation economy.